Peptide news, worldwide.
A live, positive-sentiment feed of peptide research, metabolic science and regenerative medicine — curated hourly from global sources.
Fresh stories
Nothing new in the last 48 hours — see the archive below.
Past articles
Older positive-sentiment coverage we've saved from the feed.
Lilly's oral GLP-1, Foundayo , demonstrated cardiovascular safety alongside sustained A1C reduction and weight loss in its largest and longest type 2 diabetes study - Investing News Network
Lilly's oral GLP-1, Foundayo , demonstrated cardiovascular safety alongside sustained A1C reduction and weight loss in its largest and longest type 2 diabetes study Investing News Network
Read sourceGut Hormones GLP-1 and GIP Emerge as Unexpected Players in Women’s Health - Bioengineer.org
Gut Hormones GLP-1 and GIP Emerge as Unexpected Players in Women’s Health Bioengineer.org
Read sourcebpc-157 tendon ligament healing evidence Your patients are asking about peptides. Are you ready to answer? ⠀ BPC-157, TB-500, GHK-Cu. These injectable peptides are trending in sports medicine and regenerative health circles, and the preclinical data is - v-shinpo.com
bpc-157 tendon ligament healing evidence Your patients are asking about peptides. Are you ready to answer? ⠀ BPC-157, TB-500, GHK-Cu. These injectable peptides are trending in sports medicine and regenerative health circles, and the preclinical data is v-shinpo.com
Read sourcePeptide Signals: Expanding Research Frontiers Through Molecular Precision - Moment Magazine
Peptide Signals: Expanding Research Frontiers Through Molecular Precision Moment Magazine
Read sourceResearchers Discover Peptide That Could Target Dementia - 1310 WIBA - Madison's News/Talk Station
Researchers Discover Peptide That Could Target Dementia 1310 WIBA - Madison's News/Talk Station
Read sourceThe New Generation of Peptides: Why Emerging Compounds Are Getting Attention - finehomesandliving.com
The New Generation of Peptides: Why Emerging Compounds Are Getting Attention finehomesandliving.com
Read sourceNeuroplasticity After Brain Injury: Why Peptide Signalling Is Becoming a Research Focus - London Post
Neuroplasticity After Brain Injury: Why Peptide Signalling Is Becoming a Research Focus London Post
Read sourceLarge study finds GLP-1 drugs may lower fracture risk in Type 2 diabetes - Managed Healthcare Executive
Large study finds GLP-1 drugs may lower fracture risk in Type 2 diabetes Managed Healthcare Executive
Read sourceLilly presents early data supporting GLP-1/GIP candidate's potential in depression, alcohol use disorder - BioSpace
Lilly presents early data supporting GLP-1/GIP candidate's potential in depression, alcohol use disorder BioSpace
Read sourceRNA therapy may help preserve muscle during GLP-1 weight loss - Medical Xpress
RNA therapy may help preserve muscle during GLP-1 weight loss Medical Xpress
Read sourceGLP-1 Systematic Review Finds Weight Loss of Up to 24% - Medscape
GLP-1 Systematic Review Finds Weight Loss of Up to 24% Medscape
Read sourceStudy Helps Pinpoint Who Gains Kidney Benefits From GLP-1s and SGLT-2s - technologynetworks.com
Study Helps Pinpoint Who Gains Kidney Benefits From GLP-1s and SGLT-2s technologynetworks.com
Read sourceGLP-1s Could Help Older Adults With Frailty - everydayhealth.com
GLP-1s Could Help Older Adults With Frailty everydayhealth.com
Read sourceTeitur reports positive early data for Parkinson’s peptide TT‑P34 - PharmaTimes
Teitur reports positive early data for Parkinson’s peptide TT‑P34 PharmaTimes
Read sourcePeptide Biofungicide Advances Toward US, EU Approval - Global Agriculture
Peptide Biofungicide Advances Toward US, EU Approval Global Agriculture
Read sourceThis Drug May Cut Asthma Attacks By Nearly 40%, New Research Suggests - MindBodyGreen
This Drug May Cut Asthma Attacks By Nearly 40%, New Research Suggests MindBodyGreen
Read sourceLaboratoire PYC launches Blue Cell Elixir nutricosmetic with peptide complex - Nutraceutical Business Review
Laboratoire PYC launches Blue Cell Elixir nutricosmetic with peptide complex Nutraceutical Business Review
Read sourceThe Peptide Research Sector Is Quietly Becoming One of Canada’s Fastest-Growing Biotech Segments - Barchart.com
The Peptide Research Sector Is Quietly Becoming One of Canada’s Fastest-Growing Biotech Segments Barchart.com
Read sourceThe Peptide Behind the New Wave Non-Needle Firming Creams - USA Today
The Peptide Behind the New Wave Non-Needle Firming Creams USA Today
Read source2026 Gill Symposium to honor leading researchers behind GLP-1 and incretin biology breakthroughs - news.iu.edu
2026 Gill Symposium to honor leading researchers behind GLP-1 and incretin biology breakthroughs news.iu.edu
Read sourceBioLife Secures U.S. Patent for First-of-its-kind Effervescent Oral Peptide Delivery Technology - Business Wire
BioLife Secures U.S. Patent for First-of-its-kind Effervescent Oral Peptide Delivery Technology Business Wire
Read sourceOzempic's Active Ingredient Linked to Lower Hospitalization Risk in Bipolar Disorder - Discover Magazine
Ozempic's Active Ingredient Linked to Lower Hospitalization Risk in Bipolar Disorder Discover Magazine
Read sourceDigital companion apps help secure long-term habits during GLP-1 therapy - News-Medical
Digital companion apps help secure long-term habits during GLP-1 therapy News-Medical
Read sourceScientists Found a Surprising Effect of Ozempic. It Involves Your Lungs - Gizmodo
Scientists Found a Surprising Effect of Ozempic. It Involves Your Lungs Gizmodo
Read sourceNew study links GLP-1 ingredient to decrease in asthma attacks, COPD flare-ups - Scripps News
New study links GLP-1 ingredient to decrease in asthma attacks, COPD flare-ups Scripps News
Read sourceBeyond the prescription: How GLP-1 companion digital programs address persistence to medication and postcessation weight regain - EurekAlert!
Beyond the prescription: How GLP-1 companion digital programs address persistence to medication and postcessation weight regain EurekAlert!
Read sourceOzempic and Wegovy linked to nearly 40% fewer asthma attacks - Science Daily
Ozempic and Wegovy linked to nearly 40% fewer asthma attacks Science Daily
Read sourceNew GLP-1 review shows weight loss drugs are getting stronger - diabetes.co.uk
New GLP-1 review shows weight loss drugs are getting stronger diabetes.co.uk
Read sourceCould GLP-1 Medications Change the Future of Ovarian Cancer Care? - Baptist Health
Could GLP-1 Medications Change the Future of Ovarian Cancer Care? Baptist Health
Read sourceGLP-1s May Reduce Asthma Attack Frequency, Study Suggests - Everyday Health
GLP-1s May Reduce Asthma Attack Frequency, Study Suggests Everyday Health
Read sourceOzempic and Wegovy may have an unexpected mental health benefit - Science Daily
Ozempic and Wegovy may have an unexpected mental health benefit Science Daily
Read sourceMore Kids Using GLP-1 Drugs To Fight Obesity - U.S. News & World Report
More Kids Using GLP-1 Drugs To Fight Obesity U.S. News & World Report
Read sourceReview of randomized controlled trials supports safety and effectiveness of GLP-1 medications for obesity - Substack
Review of randomized controlled trials supports safety and effectiveness of GLP-1 medications for obesity Substack
Read sourceWhy GLP-1s Could Be an Anti-Aging Breakthrough - National Geographic
Why GLP-1s Could Be an Anti-Aging Breakthrough National Geographic
Read sourceGLP-1 treatment linked to 40% fewer asthma attacks - News-Medical
GLP-1 treatment linked to 40% fewer asthma attacks News-Medical
Read sourceSemaglutide linked to 20% fewer COPD flare-ups and nearly 40% fewer asthma attacks - Medical Xpress
Semaglutide linked to 20% fewer COPD flare-ups and nearly 40% fewer asthma attacks Medical Xpress
Read sourceGLP-1s Tied to Metabolic Benefits in Rheumatology Patients - Medscape
GLP-1s Tied to Metabolic Benefits in Rheumatology Patients Medscape
Read sourceSleep Apnea: Can GLP-1 Drugs Like Zepbound Help With Symptoms? - Healthline
Sleep Apnea: Can GLP-1 Drugs Like Zepbound Help With Symptoms? Healthline
Read sourceGLP-1 Meds Linked to Symptomatic Remission in Ulcerative Colitis - Medscape
GLP-1 Meds Linked to Symptomatic Remission in Ulcerative Colitis Medscape
Read sourceLu-LNC1010 Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors - jnm.snmjournals.org
Lu-LNC1010 Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors jnm.snmjournals.org
Read sourceLow-dose GLP-1 users lose weight, but not the double digits - Benefits and Pensions Monitor
Low-dose GLP-1 users lose weight, but not the double digits Benefits and Pensions Monitor
Read sourceMounjaro: FDA Approves GLP-1 for Cardiovascular Risk Reduction - Healthline
Mounjaro: FDA Approves GLP-1 for Cardiovascular Risk Reduction Healthline
Read sourceGLP-1 agonist semaglutide slows aging in mice - C&EN
GLP-1 agonist semaglutide slows aging in mice C&EN
Read sourceGLP-1 weight-loss medication could slow aging and extend lifespan - Yahoo Health
GLP-1 weight-loss medication could slow aging and extend lifespan Yahoo Health
Read sourceCould GLP-1 weight-loss drugs help you live longer? - Scientific American
Could GLP-1 weight-loss drugs help you live longer? Scientific American
Read sourceMounjaro's Label Expands; Type 1 Diabetes on the Rise; Testosterone and Afib - MedPage Today
Mounjaro's Label Expands; Type 1 Diabetes on the Rise; Testosterone and Afib MedPage Today
Read sourceCardiac Research: Exploring Regulatory Compounds and Their Expanding Scientific Relevance - Indiana Daily Student
Cardiac Research: Exploring Regulatory Compounds and Their Expanding Scientific Relevance Indiana Daily Student
Read sourceGLP-1 RAs produce significant weight loss in adults without diabetes, with newer treatments showing greater results - Medical Xpress
GLP-1 RAs produce significant weight loss in adults without diabetes, with newer treatments showing greater results Medical Xpress
Read sourceWhy Personalized and Regenerative Medicine Is Changing Aesthetic Medicine Training in 2026 - EIN Presswire
Why Personalized and Regenerative Medicine Is Changing Aesthetic Medicine Training in 2026 EIN Presswire
Read sourceGLP-1s do not cause major psychiatric harm, according to new study - Medical Xpress
GLP-1s do not cause major psychiatric harm, according to new study Medical Xpress
Read sourceNewer GLP-1 agents yield substantial weight loss in nondiabetic adults - 2minutemedicine.com
Newer GLP-1 agents yield substantial weight loss in nondiabetic adults 2minutemedicine.com
Read sourceFDA Approves Mounjaro (Tirzepatide) For Reducing Cardiovascular Risk In Adults with Type 2 Diabetes. Here Are The Best GLP-1 Providers - Forbes
FDA Approves Mounjaro (Tirzepatide) For Reducing Cardiovascular Risk In Adults with Type 2 Diabetes. Here Are The Best GLP-1 Providers Forbes
Read sourceTirzepatide Receives Expanded Approval for MACE in Patients With T2D - Drug Topics
Tirzepatide Receives Expanded Approval for MACE in Patients With T2D Drug Topics
Read sourceGLP-1 Drugs Making You Lose Muscle Along With Fat? Scientists Discover Game Changing Weight-Loss Compound To Tackle It - Health and Me
GLP-1 Drugs Making You Lose Muscle Along With Fat? Scientists Discover Game Changing Weight-Loss Compound To Tackle It Health and Me
Read sourceGLP-1 drugs cut US obesity from 39.9% to 36.4% - The News International
GLP-1 drugs cut US obesity from 39.9% to 36.4% The News International
Read sourceMultiagonists Outpace Older GLP-1 Drugs for Weight Loss - The American Journal of Managed Care
Multiagonists Outpace Older GLP-1 Drugs for Weight Loss The American Journal of Managed Care
Read sourceAll About Peptides: Making the Most of Longevity Medicine’s Latest Development - WorldHealth.net
All About Peptides: Making the Most of Longevity Medicine’s Latest Development WorldHealth.net
Read sourceCan GLP-1 Drugs Help Veterans Lower Alcohol Use? What New Research Shows - military.com
Can GLP-1 Drugs Help Veterans Lower Alcohol Use? What New Research Shows military.com
Read sourceFDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes - The American Journal of Managed Care
FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes The American Journal of Managed Care
Read sourceLilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist Mounjaro - BioSpace
Lilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist Mounjaro BioSpace
Read sourcePeptide vaccine targeting PCSK9 reduces cholesterol and atherosclerotic plaque in mice - Drug Target Review
Peptide vaccine targeting PCSK9 reduces cholesterol and atherosclerotic plaque in mice Drug Target Review
Read sourceNew study: Could GLP-1s help stop breast cancer recurrence? - KERA News
New study: Could GLP-1s help stop breast cancer recurrence? KERA News
Read sourceGLP-1's shocking side effect: curbing violent crime - Audacy
GLP-1's shocking side effect: curbing violent crime Audacy
Read sourceCould GLP-1 drugs prevent blood cancers and other diseases of ageing? - ndph.ox.ac.uk
Could GLP-1 drugs prevent blood cancers and other diseases of ageing? ndph.ox.ac.uk
Read sourceVector Science and Therapeutics (TSXV:PAIN) Rises 6.1% as Peptide Production Begins - kalkine.ca
Vector Science and Therapeutics (TSXV:PAIN) Rises 6.1% as Peptide Production Begins kalkine.ca
Read sourceAdvancing peptide bioanalysis for drug development - News-Medical
Advancing peptide bioanalysis for drug development News-Medical
Read sourcePeptide Synthesis Market worth $1.54 billion by 2031 - Exclusive Report by MarketsandMarkets™ - PR Newswire
Peptide Synthesis Market worth $1.54 billion by 2031 - Exclusive Report by MarketsandMarkets™ PR Newswire
Read sourceGenesis Regenerative Launches the Roadmap to Health, Pairing Genomic Testing With Regenerative Proteins and Peptides - EIN Presswire
Genesis Regenerative Launches the Roadmap to Health, Pairing Genomic Testing With Regenerative Proteins and Peptides EIN Presswire
Read sourceCDT Equity Inc. Enters SAFE Note Agreement with Pep’d Inc. to Expand Exposure to US Peptide Market - Quiver Quantitative
CDT Equity Inc. Enters SAFE Note Agreement with Pep’d Inc. to Expand Exposure to US Peptide Market Quiver Quantitative
Read sourceGLP-1 Drugs Could Help Treat Addiction, Researchers See Promising Results for Alcohol and Other Substances - NCHStats
GLP-1 Drugs Could Help Treat Addiction, Researchers See Promising Results for Alcohol and Other Substances NCHStats
Read sourceResearchers link GLP-1 drugs to lower tuberculosis risk in type 2 diabetes - News-Medical
Researchers link GLP-1 drugs to lower tuberculosis risk in type 2 diabetes News-Medical
Read sourceWeight-loss drug may lower risk of heart attacks and infections - Harvard Health
Weight-loss drug may lower risk of heart attacks and infections Harvard Health
Read sourceSmart probiotics can sense high blood sugar and release GLP-1 on demand - Medical Xpress
Smart probiotics can sense high blood sugar and release GLP-1 on demand Medical Xpress
Read sourceUnexpected GLP-1 side effect? Studies show the meds may help people with addictions - NewsNation
Unexpected GLP-1 side effect? Studies show the meds may help people with addictions NewsNation
Read sourceExperimental compound helps burn fat without muscle loss - Science Daily
Experimental compound helps burn fat without muscle loss Science Daily
Read sourcePeptide Therapy Anti-Aging Treatments | Aspen Institute For Regenerative Medicine & Anti-Aging Dean Wade (36tbTTJCUf) - Mshale
Peptide Therapy Anti-Aging Treatments | Aspen Institute For Regenerative Medicine & Anti-Aging Dean Wade (36tbTTJCUf) Mshale
Read sourcePeptide API Market to Reach More Than USD 94.2 Billion by 2034, - openPR.com
Peptide API Market to Reach More Than USD 94.2 Billion by 2034, openPR.com
Read sourceThe Benefits of Peptides - Generation Iron
The Benefits of Peptides Generation Iron
Read sourcePursuing patient options, Novo kicks off trial testing smaller doses of Wegovy pill - Fierce Pharma
Pursuing patient options, Novo kicks off trial testing smaller doses of Wegovy pill Fierce Pharma
Read sourceNew study may change how we think about GLP-1s - Technology Org
New study may change how we think about GLP-1s Technology Org
Read sourceSpinach peptide discovery leads to citrus greening treatment - AgriLife Today
Spinach peptide discovery leads to citrus greening treatment AgriLife Today
Read sourceResearchers looking into whether GLP-1 drugs can help slow aging - Yahoo
Researchers looking into whether GLP-1 drugs can help slow aging Yahoo
Read sourceNuritas' PeptiSleep shows improved sleep quality and HRV - Nutraceutical Business Review
Nuritas' PeptiSleep shows improved sleep quality and HRV Nutraceutical Business Review
Read source5 Research Peptide Companies Raising the Bar for Quality and Transparency in 2026 - Technology Org
5 Research Peptide Companies Raising the Bar for Quality and Transparency in 2026 Technology Org
Read sourceCould GLP-1s help with alcohol use disorder? A Philly VA doctor is leading a national trial to find out. - Inquirer.com
Could GLP-1s help with alcohol use disorder? A Philly VA doctor is leading a national trial to find out. Inquirer.com
Read sourceCould GLP-1 drugs hold the key to longevity? - Good Morning America
Could GLP-1 drugs hold the key to longevity? Good Morning America
Read sourceResearchers looking into whether GLP-1 drugs can help slow aging - ABC7 Eyewitness News
Researchers looking into whether GLP-1 drugs can help slow aging ABC7 Eyewitness News
Read sourcePeptide Synthesis Market: USD 2.59 Billion by 2031, Driven by Therapeutic Demand & Advanced Synthesis Technologies, Says Mordor Intelligence - The AI Journal
Peptide Synthesis Market: USD 2.59 Billion by 2031, Driven by Therapeutic Demand & Advanced Synthesis Technologies, Says Mordor Intelligence The AI Journal
Read sourceCould GLP-1s help treat opioid use disorder? Vanderbilt Health study now enrolling - Vanderbilt Health News
Could GLP-1s help treat opioid use disorder? Vanderbilt Health study now enrolling Vanderbilt Health News
Read sourceFlorida State University expert explores potential GLP-1 link to binge-eating improvements - Florida State University News
Florida State University expert explores potential GLP-1 link to binge-eating improvements Florida State University News
Read sourceAmylyx’s bet on a GLP-1 blocker pays off - BioPharma Dive
Amylyx’s bet on a GLP-1 blocker pays off BioPharma Dive
Read sourceAmylyx declares late-stage win with a GLP-1 antagonist in its post-ALS reset - Endpoints News
Amylyx declares late-stage win with a GLP-1 antagonist in its post-ALS reset Endpoints News
Read sourceMillions of Aussie adults eligible for weight loss drugs - The West Australian
Millions of Aussie adults eligible for weight loss drugs The West Australian
Read sourceScientists Are Discovering Unexpected Benefits of GLP-1 Drugs - SciTechDaily
Scientists Are Discovering Unexpected Benefits of GLP-1 Drugs SciTechDaily
Read sourceThe bootlace worm found washed up on Scottish beaches can stretch to more than 55 metres when uncoiled, making it longer than a blue whale, and its mucus contains a peptide that paralysed crabs and killed or permanently paralysed juvenile cockroaches i - Silicon Canals
The bootlace worm found washed up on Scottish beaches can stretch to more than 55 metres when uncoiled, making it longer than a blue whale, and its mucus contains a peptide that paralysed crabs and killed or permanently paralysed juvenile cockroaches i Silicon Canals
Read sourceScreening for Confidence Tailors GLP-1 Care - Medscape
Screening for Confidence Tailors GLP-1 Care Medscape
Read sourceGLP-1 levels increased with OEA supplementation - Study - NutraIngredients.com
GLP-1 levels increased with OEA supplementation - Study NutraIngredients.com
Read sourceGLP-1 Receptor Agonists in Migraine and Intracranial Hypertension: Emerging Off-Label Therapeutic Potential - News-Medical
GLP-1 Receptor Agonists in Migraine and Intracranial Hypertension: Emerging Off-Label Therapeutic Potential News-Medical
Read sourceFlorida State University Expert Explores Potential GLP-1 Link to Binge-Eating Improvements | Newswise - Newswise
Florida State University Expert Explores Potential GLP-1 Link to Binge-Eating Improvements | Newswise Newswise
Read sourceChristoph Deinzer: Research on EWSR1–FLI1 Peptide Vaccine in Metastatic Ewing Sarcoma Published - Oncodaily
Christoph Deinzer: Research on EWSR1–FLI1 Peptide Vaccine in Metastatic Ewing Sarcoma Published Oncodaily
Read source